ZeCardio Therapeutics 

Keep the Heart Beating!

OWNER

Davide D'Amico (See Profile)


Sector

Biotech

Stage

Prototyping, preclinical

Country

Spain


Novel approach to identify cardiovascular drugs, with higher prediction than classical preclinical tools

Proprietary technology platform, ZeCardio, based on zebrafish, robotics and IT, top-ranked SMEInst2 from H2020

Unique market niche with high potential return of investment and global pharmaceutical network

Experiences team of scientists-entrepreneurs with track record in the field and stories of success on the background

Spin-out from a pioneer biotech crowd-funded company, ZeClinics, which gave already returns to crowd-investors

This information is confidential, do not share or copy.

You can visit their website or

Download the Pitch Deck

Under evaluation at least till: 5th December

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar